Skip to main content
. 2010 Aug;51(8):2405–2412. doi: 10.1194/jlr.P900015

TABLE 1.

Characteristics of morbidly obese women before and 12 months after gastric bypass surgery and of age-matched healthy control subjects

Gastric Bypass Patients (n = 19)
Variable Controls (n = 19) Baseline 12 months
Age (year) 44 ± 4 41 ± 8 42 ± 8
BMI (kg/m2) 25 ± 4 46 ± 8a 31 ± 5ab
Fat mass (kg) NA 67 ± 15 33 ± 8b
Lean mass (kg) NA 63 ± 14 46 ± 5b
Waist/hip ratio 0.82 ± 0.1 0.95 ± 0.1a 0.88 ± 0.1ab
Fasting glucose 84 ± 10 100 ± 20a 83 ± 5b
Fasting insulin (IU) 9 ± 7 33 ± 16a 11 ± 3ab
HOMA-IR 1.7 ± 0.8 8.5 ± 5.7a 2.3 ± 0.7ab
Total-C 203 ± 48 147 ± 31a 133 ± 24a
LDL-C 121 ± 41 98 ± 29a 81 ± 19ab
HDL-C 59 ± 14 37 ± 10a 46 ± 8ab
LDL/HDL 2.2 ± 1.0 2.6 ± 0.7 1.9 ± 0.5b
HDL-TGa NA 19.4 ± 7.5 15.5 ± 5.3b
TGa 112 ± 58 141 ± 105a 84 ± 51b
RLP-C 4.7 ± 2.4 7.4 ± 6.7a 4.0 ± 3.6b
Apo A-I 156 ± 23 108 ± 25a 117 ± 26
Apo A-II 37 ± 8 24 ± 5a 23 ± 5a
Apo E 4.0 ± 0.8 3.6 ± 0.9 2.8 ± 0.6ab
LCAT mass (μg/ml) NA 9.3 ± 2.1 7.4 ± 1.6b
LCAT activityb NA 3.9 ± 1.0 2.7 ± 1.4b
CETP mass (μg/ml) NA 1.0 ± 0.3 1.1 ± 0.3
CETP activityc NA 16.5 ± 19.2 2.8 ± 18.8b
ApoA-I-containing HDL subpopulations
 Preβ-1 12.4 ± 6.5 14.3 ± 9.7 11.5 ± 7.3b
 Preβ-2 2.3 ± 1.4 2.2 ± 1.7 1.9 ± 1.4
 α-1 27.4 ± 9.2 9.0 ± 4.7a 17.3 ± 5.1ab
 α-2 55.9 ± 11.0 39.1 ± 11.2a 42.7 ± 11.0
 α-3 28.9 ± 4.7 24.8 ± 7.3 20.8 ± 7.9
 α-4 10.0 ± 3.1 10.4 ± 3.8 9.6 ± 4.0
 Preα-1 7.2 ± 3.2 1.9 ± 1.6a 4.2 ± 2.4ab
 Preα-2 8.0 ± 2.8 3.6 ± 1.8a 4.8 ± 2.4a
 Preα-3 1.9 ± 0.4 1.9 ± 0.8 1.7 ± 0.8
 Preα-4 1.0 ± 0.3 0.9 ± 0.5 0.9 ± 0.3

Values are mean ± SD (mg/dl) or as indicated. P ≤ 0.01 was selected as significantly different (Student's t-test). Letters indicate statistically significant difference from: (a) controls, (b) baseline. Conversion factor from mg/dl to mmol: for cholesterol, divide numbers by 38.88; for TG, divide numbers by 86.88.

a

Statistical test performed using log transformed values.

b

μg/ml/h CE increase in plasma.

c

μg/ml/h CE decrease in HDL.